Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1794 1
1883 3
1893 1
1899 1
1900 1
1901 1
1902 1
1910 1
1913 1
2002 1
2003 4
2004 4
2005 8
2006 8
2007 5
2008 7
2009 5
2010 2
2011 2
2012 3
2013 5
2014 2
2015 1
2017 4
2018 2
2019 7
2020 4
2021 1
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
The Peroxiredoxin Family: An Unfolding Story.
Cao Z, Lindsay JG. Cao Z, et al. Among authors: lindsay jg. Subcell Biochem. 2017;83:127-147. doi: 10.1007/978-3-319-46503-6_5. Subcell Biochem. 2017. PMID: 28271475 Review.
Look but don't touch! An alternative to the gold standard?
Baghai M, John LCH. Baghai M, et al. Among authors: john lch. J Thorac Cardiovasc Surg. 2017 Aug;154(2):467-468. doi: 10.1016/j.jtcvs.2017.04.007. Epub 2017 Apr 12. J Thorac Cardiovasc Surg. 2017. PMID: 28479055 Free article. No abstract available.
An unusual headache.
Graham UM, Magorrian M, Burns P, Lindsay JR. Graham UM, et al. Among authors: lindsay jr. BMJ. 2014 Sep 16;349:g5602. doi: 10.1136/bmj.g5602. BMJ. 2014. PMID: 25228308 No abstract available.
Adrenal disorders in pregnancy.
Lindsay JR, Nieman LK. Lindsay JR, et al. Endocrinol Metab Clin North Am. 2006 Mar;35(1):1-20, v. doi: 10.1016/j.ecl.2005.09.010. Endocrinol Metab Clin North Am. 2006. PMID: 16310640 Review. No abstract available.
83 results